Mirae Asset Global ETFs Holdings
CSTL icon

Mirae Asset Global ETFs Holdings’s Castle Biosciences CSTL Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$336K Buy
13,676
+453
+3% +$14.8K ﹤0.01% 2092
2025
Q4 		$514K Sell
13,223
-50
-0.4% -$1.61K ﹤0.01% 1881
2025
Q3 		$302K Sell
13,273
-2,288
-15% -$46.5K ﹤0.01% 2103
2025
Q2 		$318K Buy
15,561
+120
+0.8% +$2.22K ﹤0.01% 2041
2025
Q1 		$309K Buy
15,441
+655
+4% +$16.2K ﹤0.01% 2099
2024
Q4 		$394K Buy
14,786
+608
+4% +$18.5K ﹤0.01% 2042
2024
Q3 		$404K Buy
14,178
+1,162
+9% +$29.6K ﹤0.01% 2022
2024
Q2 		$283K Buy
+13,016
New +$290K ﹤0.01% 2094

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's CSTL Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Castle Biosciences (CSTL) stake by 3.4% in Q1 2026, buying an estimated $14.8K and bringing the position to 13,676 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #2092.

Mirae Asset Global ETFs Holdings first reported a position in CSTL in Q2 2024 and has held it in 8 quarters since. The position peaked at $514K in Q4 2025. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 13,676 shares of Castle Biosciences worth $336K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 453 Castle Biosciences shares in Q1 2026, an estimated $14.8K.
  • Castle Biosciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2092 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Castle Biosciences in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's Castle Biosciences position peaked at $514K in Q4 2025.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.